Parameter
| Biomarker | UT-2 | Full name | Urotensin-2 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis |
| Disease | BPH | Disease Subtypes | / | ||
| Organ | Prostate | Test Sample / Technology Platform | Plasma (ELISA) | ||
| Pathobiological Mechanisms | Regulation of cell proliferation, invasion, and angiogenesis by G protein-coupled receptors (GPR14) may be associated with the burden of systemic diseases and the metastatic microenvironment. | ||||
| Clinical Availability Status | Further validation is required during the preliminary study phase | ||||
| Notes and Dynamics | The first study on plasma UT-2 in prostate cancer, as part of a multi-parameter prognostic panel, requires prospective research to correlate treatment response with survival outcomes. | ||||